Atlas Trials

Carbergoline for Antipsychotic Induced Hyperprolactinemia.

Clinical trial NCT07386080 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07386080
Sponsor
Zealand University Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Scizophrenia
Start date
2026-05-01
Primary completion
2028-05-01
Enrollment
146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.